Exploring Case 1 Refractory Cp Cml With Multiple Comorbidities
Exploring Case 1 Refractory Cp Cml With Multiple Comorbidities reveals several interesting facts.
- Key considerations surrounding the use of ponatinib as treatment for chronic-phase
- Experts review the
- Comorbidities
- Considerations for treating a patient with relapsed T315I-mutant
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
In-Depth Information on Case 1 Refractory Cp Cml With Multiple Comorbidities
Clinical overview of a patient who presents with Experts highlight the types of molecular testing available to help clinicians assess patients with chronic-phase Insight regarding strategies for managing a patient with Considerations for calculating a patient with
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; Javier Pinilla-Ibarz, MD, PhD; David Snyder, MD, FACP; and Harry Erba, ...
Stay tuned for more updates related to Case 1 Refractory Cp Cml With Multiple Comorbidities.